This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

IntegraMed American Acquisition Lawsuit Investigation Concerning Breach Of Fiduciary Duties In Sagard Capital Acquisition Announced By Gilman Law LLP

Shareholder Rights Law Firm Gilman Law LLP has commenced a breach of fiduciary duty investigation on behalf of current shareholders of IntegraMed America, Inc. (Nasdaq: INMD) (“IntegraMed”) and other violations of state law by the board of directors of IntegraMed relating to the proposed buyout of the company by affiliates of the investment firm Sagard Capital Partners, L.P. (“Sagard Capital”). Gilman Law LLP’s investigation focuses on determining whether the board breached its fiduciary duties by failing to maximize shareholder value in the proposed InregraMed Acquisition.

Join the IntegraMed American Acquisition Lawsuit

About the IntegraMed American Acquisition Lawsuit

IntegraMed announced on June 11, 2012, that it had entered into a definitive agreement allowing Sagard Capital to acquire IntegraMed America for approximately $169.5 million. Under the terms of the IntegraMed buyout transaction, IntegraMed shareholders will receive $14.05 for each share of IntegraMed common stock held. According to sources, analysts have set a mean price target of $15.50. At least one analyst has set a high price target of $17.00 per share.

About the Shareholder Rights Law Firm Gilman Law LLP

IntegraMed shareholders who would like to learn more about the investigation may contact the Securities Attorneys at Gilman Law LLP for a free consultation, with no cost or obligation to you. Our Securities Attorneys have over 33 years of experience in securities litigation, securities arbitration, mergers & acquisitions, shareholder disputes, and other types of violations of securities laws.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,690.07 -28.47 -0.16%
S&P 500 2,056.97 -4.08 -0.20%
NASDAQ 4,862.7650 -13.7540 -0.28%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs